These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
143 related items for PubMed ID: 140084
1. Efficacy of bufexamac (NFN) cream in skin diseases. A double-blind multicentre trial. Christiansen JV, Gadborg E, Kleiter I, Ludvigsen K, Meier CH, Norholm A, Reiter H, Reymann F, Raaschou-Nielsen W, Sondergaard M, Unna P, Wehnert R. Dermatologica; 1977; 154(3):177-84. PubMed ID: 140084 [Abstract] [Full Text] [Related]
4. [Comparative testing of Kamillosan cream and steroidal (0.25% hydrocortisone, 0.75% fluocortin butyl ester) and non-steroidal (5% bufexamac) dermatologic agents in maintenance therapy of eczematous diseases]. Aertgeerts P, Albring M, Klaschka F, Nasemann T, Patzelt-Wenczler R, Rauhut K, Weigl B. Z Hautkr; 1985 Feb 01; 60(3):270-7. PubMed ID: 3158124 [Abstract] [Full Text] [Related]
5. Double-blind trial comparing bufexamac infiltrations with triamcinolone acetonide infiltrations in patients with periarthritis of the shoulder. Mardjuadi A, Dequeker J. Curr Med Res Opin; 1978 Feb 01; 5(5):401-5. PubMed ID: 350491 [Abstract] [Full Text] [Related]
6. Safety and efficacy of clocortolone pivalate 0.1 percent cream in the treatment of atopic dermatitis, contact dermatitis, and seborrheic dermatitis. Nierman MM. Cutis; 1981 Jun 01; 27(6):670-1. PubMed ID: 6453703 [No Abstract] [Full Text] [Related]
7. [Bufexamac cream and ointment for the treatment of various dermatoses]. Achten G, Bourlond A, Haven E, Lapière CM, Piérard J, Reynaers H. Dermatologica; 1973 Jun 01; 146(1):1-7. PubMed ID: 4571591 [No Abstract] [Full Text] [Related]
8. [Comparative studies with Halcinonide and fluocortolone in local administration]. Reinhard W, Weber G, Petres J. Z Hautkr; 1974 Apr 01; 49(7):267-72. PubMed ID: 4275779 [No Abstract] [Full Text] [Related]
10. [Clinical test with Apolar cream and Calmuril-hydrocortisone cream in contact dermatitis and atopic dermatitis]. Gip L. Tidsskr Nor Laegeforen; 1978 Apr 10; 98(10):509-10. PubMed ID: 354085 [No Abstract] [Full Text] [Related]
11. A double-blind clinical study of bufexamac and fluocinolone acetonide in dermatitis. Mackey JP. J Ir Med Assoc; 1974 Apr 27; 67(8):214-6. PubMed ID: 4597141 [No Abstract] [Full Text] [Related]
16. Bufexamac: a review of its pharmacological properties and therapeutic efficacy in inflammatory dermatoses. Brogden RN, Pinder RM, Sawyer PR, Speight TM, Avery GS. Drugs; 1975 Mar 27; 10(5-6):351-6. PubMed ID: 1204506 [No Abstract] [Full Text] [Related]
17. [A common and insidious side-effect: allergic contact dermatitis caused by bufexamac used in the treatment of dermatitis. Results from the Information Network of Departments of Dermatology (IDVK)]. Schnuch A, Gefeller O, Uter W. Dtsch Med Wochenschr; 2005 Dec 16; 130(50):2881-6. PubMed ID: 16342011 [Abstract] [Full Text] [Related]
18. A double-blind trial of treatment of seborrhoeic dermatitis with 2% ketoconazole cream compared with 1% hydrocortisone cream. Katsambas A, Antoniou C, Frangouli E, Avgerinou G, Michailidis D, Stratigos J. Br J Dermatol; 1989 Sep 16; 121(3):353-7. PubMed ID: 2529893 [Abstract] [Full Text] [Related]
19. [A new corticosteroid for dermatologic use]. Wortmann F. Wien Med Wochenschr; 1972 Nov 18; 122(47):701-3. PubMed ID: 4264037 [No Abstract] [Full Text] [Related]
20. A randomised, double-blind comparison of alclometasone dipropionate 0.05% cream in atopic dermatitis and other dermatoses. Panja SK, Gangopadhaya AK, Sharma SD. Indian J Dermatol; 1988 Jan 18; 33(1):1-4. PubMed ID: 3074044 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]